Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
11/2005
11/30/2005CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders
11/30/2005CN1229336C Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative
11/29/2005US6969727 Obesity; osteoporosis
11/29/2005US6969712 Alzheimer's disease; central nervous system disorders; antidepressants; antidiabetic agents; analgesics
11/29/2005US6969711 Cyclic diamine compounds and medicine containing the same
11/24/2005WO2005111000A1 7-substituted benzimidazoles and their use as inhibitors of gastric acid secretion
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261309 Imidazole compounds
11/24/2005US20050261211 Viricides; such as 2-bromo-5,6-dichlorobenzimidazole; cyclizing 4,5-dichloro-o-phenylenediamine with carbonyl di-imidazole
11/24/2005US20050260144 Benzoxazole and benzodiazole uv-a sunscreens
11/24/2005US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
11/24/2005DE102004021779A1 Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-agonists, to processes for their preparation and their use as medicaments
11/24/2005CA2566821A1 7-substituted benzimidazoles and their use as inhibitors of gastric acid secretion
11/23/2005EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain
11/23/2005EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
11/23/2005EP1597322A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/23/2005EP1597236A1 Growth promotion method
11/23/2005EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
11/23/2005EP1320522B1 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1699350A Processes and intermediates for preparing anti-cancer compounds
11/22/2005CA2109697C Oral-administration forms of a medicament containing pantoprazole
11/17/2005WO2005108375A1 Process for the preparation of telmisartan
11/17/2005WO2005108374A1 Insecticidal diazole and triazole derivatives
11/17/2005WO2005108373A1 Novel beta agonists, method for producing the same and their use as drugs
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005WO2005092866B1 New derivatives of 4, 5, 6, 7-tetrabromobenzimidazole and method of their preparation
11/17/2005WO2005091752A3 Acrylonitrile derivatives for inflammation and immune-related uses
11/17/2005WO2004082602A3 Carboxamide spirohydantoin cgrp receptor antagonists
11/17/2005US20050256176 Sulphonamide derivatives and their use as tace inhibitors
11/17/2005CA2566431A1 Process for the preparation of telmisartan
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/17/2005CA2564980A1 Novel beta agonists, method for producing the same and their use as drugs
11/16/2005EP1594505A2 Phenylglycine derivatives useful as serine protease inhibitors
11/16/2005EP1487796A4 Substituted biaryl amides as c5a receptor modulators
11/16/2005EP1326850B1 A process for the preparation of bis-benzazolyl compounds
11/16/2005CN1227247C Method for producing therapeutic agents for ulcers
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/10/2005WO2005082871A3 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/10/2005US20050250832 For increasing blood-brain barrier permeability
11/10/2005US20050250831 Peroxisome proliferator activated receptor modulators
11/10/2005US20050250763 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
11/09/2005EP1593671A1 DPP-IV inhibitors
11/09/2005EP1592772A2 5ht7 antagonists and inverse agonists
11/09/2005EP1592671A1 N-substituted (benzoimidazole-2-yl) phenyl amines, method for their production, their use as a medicament or diagnostic agent and medicament containing said substances
11/09/2005EP1592669A2 Novel substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP0943008B1 Metal mediated serine protease inhibitors
11/09/2005CN1694704A Use of (1H-benzimidazole-2-yl)-(piperazineyl)- ketaderavitive and correlative compound used as histamine H4 receptor antagonist for the treatment of allergy and asthma
11/09/2005CN1226294C Fused heteroaromatic glucokinase activators
11/09/2005CN1226284C N-sulphonyl and N-sulphinyl phenylglycinamide
11/08/2005CA2277164C Method of controlling polymer molecular weight and structure
11/08/2005CA2123691C Antiviral compositions and method for their use
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245526 Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
11/03/2005DE102004018796A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
11/03/2005CA2802600A1 Use of flibanserin in the treatment of female sexual disorders
11/02/2005EP1590333A1 Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof
11/02/2005EP1590332A1 A process for the synthesis of bisbenzimidazoles and its derivations
11/02/2005EP1590315A1 Acetoacetylation of alcohols, thiols and amines in a microreactor
11/02/2005CN1225462C New piperazine and piperidine compounds
11/01/2005US6960688 Use of compounds for the elevation of pyruvate dehydrogenase activity
11/01/2005US6960605 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
11/01/2005US6960591 Propane-1,3-dione derivative
11/01/2005US6960582 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes
11/01/2005CA2193665C Benzimidazole derivatives for the treatment and prophylaxis of virus infections
10/2005
10/27/2005WO2005100352A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005WO2004089366A8 Bicyclic compounds as nr2b receptor antagonists
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
10/27/2005CA2563386A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005CA2562369A1 Condensed pyridine derivatives useful as a28 adenosine receptor antagonists
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1427408A4 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE)
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005CN1688576A Thiophene compounds
10/26/2005CN1688194A 2, 4, 5-trisubstituted imidazoles and their use as anti-microbial agents
10/26/2005CN1224598C Naphthalene derivatives
10/25/2005US6958357 Central nervous system disorders; antiallergens; respiratory system disorders
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/20/2005WO2005097756A1 Nitrogenous heterocycle derivative and organic electroluminescent element employing the same
10/20/2005WO2005097744A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/20/2005US20050234243 Novel diketopyrrolopyrrole pigments
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050233953 Histogranin-like peptides, processes for their preparation and uses thereof
10/20/2005US20050233943 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
10/20/2005CA2560967A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity andthe monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
10/19/2005EP1585735A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
10/19/2005EP1585726A1 Fused heterocyclic derivatives as ppar modulators
10/19/2005EP1585517A1 Use of substituted 2-phenylbenzimidazoles as medicaments
10/19/2005EP1585516A2 8-trialkylsiloxy-2-methyl-9-phenyl-7-oxo-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridines
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1404656B9 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 154